key: cord-0838964-wpwe1wx7 authors: Liu, Shufeng; Selvaraj, Prabhuanand; Lien, Christopher Z.; Wu, Wells W.; Chou, Chao-Kai; Wang, Tony T. title: The PRRA insert at the S1/S2 site modulates cellular tropism of SARS-CoV-2 and ACE2 usage by the closely related Bat raTG13 date: 2020-07-21 journal: bioRxiv DOI: 10.1101/2020.07.20.213280 sha: 8fd2d636c56a1c6f52de4e22cba9f57681cea802 doc_id: 838964 cord_uid: wpwe1wx7 Biochemical and structural analyses suggest that SARS-CoV-2 is well-adapted to infecting human and the presence of four residues (PRRA) at the S1/S2 site within the Spike protein may lead to unexpected tissue or host tropism. Here we report that SARS-CoV-2 efficiently utilized ACE2 of 9 species except mouse to infect 293T cells. Similarly, pseudoviruses bearing spike protein derived from either the bat raTG13 or pangolin GX, two closely related animal coronaviruses, utilized ACE2 of a diverse range of animal species to gain entry. Removal of PRRA from SARS-CoV-2 Spike displayed distinct effects on pseudoviral entry into different cell types. Strikingly, insertion of PRRA into the raTG13 Spike selectively abrogated the usage of horseshoe bat and pangolin ACE2 but conferred usage of mouse ACE2 by the relevant pseudovirus to enter cells. Together, our findings identified a previously unrecognized effect of the PRRA insert on SARS-CoV-2 and raTG13 spike proteins. The outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 or 2019-42 nCoV) has quickly turned into a global pandemic. Multiple studies have suggested a zoonotic 43 origin of SARS-CoV-2, highlighting the potential of coronaviruses to continuously evolve in 44 wild animal reservoirs and jump to new species (Andersen et al., 2020; Zhou et al., 2020a) . 45 Various bat species are believed to be reservoirs of progenitors of diverse coronaviruses (CoVs) 46 including the severe acute respiratory syndrome (SARS)-CoV (SARS-CoV) and SARS-CoV-2. Indeed, the closest virus to SARS-CoV-2 found up to date is the bat raTG13 with over 96% (raTG13 S+PRRA), and the Pangolin GX Spike protein (Pangolin GX S) ( Fig. 2A) . We used a 126 mouse monoclonal antibody that recognizes the S2 domain of both SARS-CoV spike and SARS- 127 CoV-2 spike proteins for detection. A partial cleavage was noticed when SARS-CoV-2 Spike 128 was expressed in 293T cells and the deletion of PRRA abolished the cleaved form (Fig. 2B) . 129 Interestingly, raTG13 spike was partially cleaved even in the absence of PRRA. Insertion of The PRRA insert at the S1/S2 site distinctly modulates cell susceptibility to SARS-CoV-2 158 pseudovirions 159 Next, we sought to investigate the impact of PRRA insert on virus entry. To this end, we 160 packaged pseudoviruses bearing SARS-CoV-2 S, SARS-CoV-2 S ∆PRRA, raTG13 S, raTG13 161 S+PRRA, and Pangolin GX S. Again, we noticed a basal level of infection by pseudovirus 162 bearing SARS-CoV-2 Spike into 293T cells even in the absence of ACE2 (Fig. S2A ). This 163 finding is consistent with the observed basal level of cell-cell fusion that is mediated by SARS- CoV-2 Spike. Surprisingly, pseudovirus carrying SARS-CoV-2 S ∆PRRA consistently infected 165 Vero E6 and 293T-hACE2 cells at about half to one log10 higher than the wild type SARS-CoV-166 2 spike ( Fig. 3A and Fig. S2B ). By contrast, infection of the human lung epithelial cell line Calu-167 3 as well as the human intestinal cell line Caco-2 by the same pseudoviruses were reduced by 90-168 50%, respectively, compared to pseudoviruses bearing the wild type SARS-CoV-2 S or raTG13 169 S (Fig. 3B&C ). Among the five pseudoviruses, bat raTG13 spike appears to be the least efficient one in mediating pseudovirus entry through hACE2. Insertion of PRRA into raTG13 Spike 171 further reduced the pseudovirus entry into all cell types that were tested ( Fig. 3A-C) . Pseudovirus 172 bearing the Pangolin spike is highly infectious on 293T-hACE2 (Fig. 3A) . Interestingly, the spike protein displayed on pseudoviruses bearing SARS-CoV-2 S, raTG13 S, raTG13 S+PRRA 174 were almost completely cleaved, whereas it was noncleaved on pseudovirions carrying the 175 SARS-CoV-2 S ∆PRRA (Fig. 3D ). Pangolin GX S on the pseudovirions appears to display an 176 entirely different pattern with potentially partial cleavage (Fig. 3D) . Lastly, expression of 177 TMPRSS2 increased the infectivity of pseudoviruses bearing SARS-CoV-2, raTG13 S, and 178 raTG13 S+PRRA by about one log, but not those bearing SARS-CoV-2 S ∆PRRA and the 179 Pangolin GX S (Fig. 3E ). The novel S1/S2 site alters the dependence of raTG13 pseudovirus on ACE2 of different 182 species 183 The PRRA insert between S1/S2 boundary of SARS-CoV-2 Spike is suspected to alter stability, To compare the usage of ACE2 from different species by SARS-CoV-2 and raTG13, we This study also revealed a rather convoluted role of the PRRA insert between S1 and S2 subunits 231 in SARS-CoV-2 entry. The presence of PRRA in SARS-CoV-2 clearly resulted in one (or two) 232 cleavage site(s). However, at least on 293T-hACE2 cells, pseudovirus bearing SARS-CoV-2 S 233 ∆PRRA exhibited even greater infectivity, suggesting that PRRA is dispensable to the Spike-234 driven viral entry. The raTG13 spike, which does not contain the PRRA sequence, is readily cleavable under the same condition. Addition of PRRA to raTG13 Spike further enhanced the 236 cleavage but decreased the relevant pseudovirus infectivity on 293T-hACE2 cells, indicating that 237 addition of PRRA does not enhance raTG13 Spike-driven entry. It is worth mentioning that 238 SARS-CoV-2 and raTG13 spike protein sequences are identical within 76 residues downstream 239 and upstream of the PRRA S1/S2 site (Supplemental Information). We envision that SARS-240 CoV-2 and raTG13 spike may adopt different structure conformations near the S1/S2 boundary 241 such that the exact region within SARS-CoV-2 is less accessible as opposed to that in raTG13. The PRRA insert appears to be essential for efficient Spike-dependent pseudovirus entry into the The most striking finding of this study is that insertion of PRRA into the raTG13 spike protein 276 altered the ability of relevant pseudovirus to utilize ACE2 of three species to gain entry. ACE2 lies between the receptor binding motif of spike protein and several residues of ACE2. Based on the known structure of SARS-CoV-2 spike protein, PRRA is part of a protruding loop 287 that is rather distal to the RBD, hence is not expected to modulate Spike-ACE2 interaction. Binding of RBD to ACE2 locks the spike protein into a conformation such that the S1/S2 289 becomes more accessible to proteolytic cleavage and hence primes the fusion peptide for 2 spike protein at the S1/S2 site. Also refer to Table S1 . Table S1 . What does this mean for re-emergence? bioRxiv. Wu, A., Peng, Y., Huang, B., Ding, X., Wang, X., Niu, P., Meng, J., Zhu, Z., Zhang, Z., Wang, On the origin and continuing evolution of 609 SARS-CoV-2 National Science Review An Infectious cDNA Clone of SARS Structural basis for the 616 recognition of SARS-CoV-2 by full-length human ACE2 Distinct conformational states of SARS-CoV-620 2 spike protein. bioRxiv Insights into the cross-623 species evolution of 2019 novel coronavirus Robust hepatitis C virus infection in vitro A Novel Bat Coronavirus Closely Related to SARS-CoV-2 Contains Natural Insertions at the S1/S2 Cleavage Site of the Spike Protein A pneumonia outbreak associated with a new coronavirus of 635 probable bat origin Coronaviruses -drug 638 discovery and therapeutic options GeneTex Cat # GTX632604 SARS-CoV-2 S2 rabbit serum Gift